scholarly journals Quality testing of veterinary antimicrobial products used for livestock in Vietnam, 2018–2019

PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0247337
Author(s):  
Huong Luu Quynh ◽  
Thuy Nguyen Thi Bich ◽  
Long Ta Hoang ◽  
Vera Irene Erickson ◽  
Pawin Padungtod

Access to quality veterinary antimicrobial products contributes to efficient treatment of diseases in Vietnamese livestock and to reducing antimicrobial resistance (AMR). Poor quality antimicrobial drugs can lead to treatment failure, potentially influencing the inappropriate use of antimicrobials products, including increasing the dose, combining drugs, or changing to a broader spectrum antimicrobial. The objective of the study was to determine the actual concentration of antimicrobial active ingredient (AAI) in commercially available veterinary antimicrobial products as an indicator of their quality. A total of 144 veterinary antimicrobial products were purchased from randomly selected veterinary drug stores in 34 districts in eight provinces. For the qualitative analysis, we observed criteria linked to form, colour, and labelling information according to the Department of Animal Health regulations. For the quantitative analysis, high-performance liquid chromatography was used to determine the actual concentration of AAI in each sample. Of the 144 samples, 131 (91%) met the national standard of quality of being within ±10% of the labelled concentration. Ten antimicrobials (6.9%) contained less than half of the labelled content concentrations. Veterinary antimicrobial product quality control is an important part of addressing AMR. To support the national action plan to lower AMR, a veterinary drug quality control program should be implemented at all stages of the supply chain to assure high quality drugs and effective treatment of sick animals.

2015 ◽  
Vol 60 (1) ◽  
pp. 632-636 ◽  
Author(s):  
Maria Siopi ◽  
Efthymios Neroutsos ◽  
Kalliopi Zisaki ◽  
Maria Gamaletsou ◽  
Maria Pirounaki ◽  
...  

ABSTRACTVoriconazole levels were determined with high-performance liquid chromatography (HPLC) and a microbiological agar diffusion assay using aCandida parapsilosisisolate in 103 serum samples from an HPLC-tested external quality control program (n= 39), 21 patients receiving voriconazole monotherapy (n= 39), and 7 patients receiving combination therapy (n= 25). The results of the bioassay were correlated with the results obtained from the external quality control program samples and with the HPLC results in sera from patients on voriconazole monotherapy and on combination therapy with an echinocandin (Spearman's rank correlation coefficient [rs], > 0.93; mean ± standard error of the mean [SEM] % difference, <12% ± 3.8%).


Author(s):  
Jung Keun Choi ◽  
Mi A Son ◽  
Hyun Kyung Kim ◽  
Domyung Paek ◽  
Byung Soon Choi

1999 ◽  
Vol 34 (6) ◽  
pp. 738-744 ◽  
Author(s):  
Agnès Ricard-Hibon ◽  
Charlotte Chollet ◽  
Sylvie Saada ◽  
Bertrand Loridant ◽  
Jean Marty

1995 ◽  
Vol 37 ◽  
pp. S56
Author(s):  
Enrico Crippa ◽  
Maria Morelli ◽  
Giorgio Mazzotti ◽  
Giuseppe Gnani

Sign in / Sign up

Export Citation Format

Share Document